Clinical trial
Pegintron Induction Therapy in HCV Non-Responders
NCT00363259 · Foundation for Liver Research, Other · Completed
Key facts
| NCT number | NCT00363259 |
|---|---|
| Title | Pegintron Induction Therapy in HCV Non-Responders |
| Official title | Pegintron Induction Therapy in Previous Non-Responders With Chronic HCV: A Dutch Multicenter Randomized Controlled Trial. (PIT-Study) |
| Lead sponsor | Foundation for Liver Research, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Peginterferon alfa-2b, Ribavirin |
| Enrollment | 110 |
| Start date | Jul 1, 2002 |
| Completion | Nov 1, 2005 |
| First posted | Aug 15, 2006 |
| Last update posted | Aug 15, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: